Are our patients better off with drug-eluting stents in saphenous vein grafts?

JACC Cardiovasc Interv. 2009 Nov;2(11):1113-5. doi: 10.1016/j.jcin.2009.09.007.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Angioplasty, Balloon, Coronary / adverse effects
  • Angioplasty, Balloon, Coronary / instrumentation*
  • Angioplasty, Balloon, Coronary / mortality
  • Coronary Artery Bypass / adverse effects*
  • Coronary Artery Bypass / mortality
  • Coronary Restenosis / etiology
  • Coronary Restenosis / mortality
  • Coronary Restenosis / therapy*
  • Drug-Eluting Stents*
  • Graft Occlusion, Vascular / etiology
  • Graft Occlusion, Vascular / mortality
  • Graft Occlusion, Vascular / therapy*
  • Humans
  • Myocardial Infarction / etiology
  • Patient Selection
  • Prosthesis Design
  • Risk Assessment
  • Risk Factors
  • Saphenous Vein / transplantation*
  • Thrombosis / etiology
  • Time Factors
  • Treatment Outcome